10月16日 - ** 农用化学品制造商FMC（FMC.N）的股价在盘前交易中下跌2.1%，至5.50美元
** FMC周四大幅下调第三季度业绩预期，并预计因降价及调整美国定价模式将产生高达6.75亿美元的费用
** 该公司股价周四暴跌逾30%
FMC受分析师下调评级影响
** 瑞穗证券（评级“跑赢大盘”）将目标价从12美元下调至10美元
**该券商预计，受非专利产品竞争影响，全行业定价压力将持续存在，尤其是在拉丁美洲；并指出FMC持续面临的定价挑战是此次下调的主要原因
** 补充道：“我们认为管理层已经尝试了
几乎所有办法，这可能是最后一个可用的手段”
** 杰富瑞将FMC评级从“买入”下调至“持有”；将目标价从14美元下调至5美元
** 杰富瑞表示：“当前农药市场仍处于低谷，该公司已下调了大量专利期已过的农药产品的价格”
** 摩根大通(中性) 将目标价从12美元下调至6美元
** 报告称，FMC似乎正通过降低价格和向客户提供返利来消化6.25亿至6.75亿美元的费用，尽管这些定价措施最终对现金流的影响尚不明确
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.